Skip to main content
HWKN
NASDAQ Trade & Services

Hawkins Reports Record Q3 Revenue & Profit, EPS Down Due to Acquisition Costs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
7
Price
$153.75
Mkt Cap
$3.212B
52W Low
$98.3
52W High
$186.15
52W Position info
56% above low
Off High info
17% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

HWKN sits 56% above its 52-week low of $98.3.

Summary

Hawkins, Inc. announced record third-quarter revenue, gross profit, operating income, and adjusted EBITDA, driven by strong growth in its Water Treatment and Industrial Solutions segments, though diluted EPS decreased due to acquisition-related expenses.


Key Events · Earnings and Guidance · HWKN

  • Record Third Quarter Performance

    Hawkins achieved record revenue of $244.1 million (up 8%), gross profit of $50.8 million (up 5%), operating income, and adjusted EBITDA of $34.8 million (up 3%) for the fiscal third quarter.

  • Mixed Segment Growth

    The Water Treatment segment sales surged 21% and Industrial Solutions grew 10%, while the Food & Health Sciences segment experienced a 10% sales decline.

  • EPS Decline with Pro Forma Growth

    Diluted EPS decreased 4% to $0.69, primarily due to approximately $5 million in acquisition-related amortization and interest expenses. However, pro forma EPS, adjusting for acquisition timing, would have been 10% higher.

  • Debt Reduction and Acquisitions

    The company generated $35 million in operating cash flow, used to pay down $15 million of debt, reducing its leverage ratio below 1.5x. This quarter also saw the completion of the sixth acquisition in fiscal 2026.


Analysis · HWKN · Trade & Services

Hawkins, Inc.'s fiscal third-quarter results demonstrate robust top-line growth and strategic expansion through acquisitions, achieving record revenue, gross profit, operating income, and adjusted EBITDA. While diluted earnings per share saw a slight decrease, this was primarily attributed to increased amortization and interest expenses from recent acquisitions, with pro forma EPS showing a 10% increase. The company also significantly reduced debt, lowering its leverage ratio. The decline in the Food & Health Sciences segment presents a challenge, which management aims to address by returning to organic growth in fiscal 2027. Overall, the report indicates a company actively executing its growth strategy and managing its balance sheet effectively, despite some near-term impacts on GAAP earnings.

At the time of this filing, HWKN was trading at $153.75 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $98.30 to $186.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HWKN - Latest Insights

HWKN
May 13, 2026, 4:14 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $161.83
Real-time Price: $139.03 info
Change: -$22.80 (-14%) info
Market Cap: $2.907B info
HWKN
May 13, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $161.83
Real-time Price: $139.03 info
Change: -$22.80 (-14%) info
Market Cap: $2.907B info
HWKN
May 13, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $166.68
Real-time Price: $139.03 info
Change: -$27.65 (-17%) info
Market Cap: $2.907B info
HWKN
Apr 30, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $167.45
Real-time Price: $139.03 info
Change: -$28.42 (-17%) info
Market Cap: $2.907B info
HWKN
Jan 28, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $153.75
Real-time Price: $139.03 info
Change: -$14.72 (-10%) info
Market Cap: $2.907B info